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Abstract  
Introduction: Coronary artery disease (CAD) is a costly problem and its presentations and risk factors may 
differ by sex.  
Objective: This study aimed to evaluate the risk factors profile and angiographic pattern of the patients 
undergoing coronary angiography, according to their gender.  
Methods: This cross-sectional study was conducted on 741 patients who were referred for coronary 
angiography from March to August 2018 at Imam Ali cardiovascular center, western Iran. Using a checklist, 
we collected the demographic, clinical, biochemical, and lab parameters and angiographic findings in these 
patients. Also, differences between groups were compared using Chi-square and independent t-tests. 
Results: Women were different from men in terms of the prevalence of hypertension (71.7% vs. 45.3%), 
diabetes mellitus (34.9% vs. 17.8%), and hypercholesterolemia (26.4% vs. 17.1%). Whereas, men were more 
likely to be smoker (28.7% vs. 0%) and obese (42.09±16.68 vs. 29.12±4.72). Total Cholesterol and 
Triglycerides were higher in women compared to men, which were statistically significant. Glucose plasma 
was significantly higher in women compared to men (p=0.01).  Both atherogenic (low-density lipoprotein 
(LDL)) and protective (high-density lipoprotein (HDL)) cholesterol were higher in women than men. Women 
were more likely to take antiplatelet (i.e. Aspirin) and antihypertensive therapies (i.e. beta-Blocker, 
angiotensin receptor blockers (ARBs), and angiotensin converting enzyme (ACE) inhibitors) than men. Also, 
it was shown that, Men were more likely to have two-vessel disease (p=0.041) and three-vessel disease 
(P=0.013) compared to women. Disease in the right coronary artery (RCA) (28.9% vs. 14.4%), circumflex 
(LCx) (26.0% vs. 15.3%), and left anterior descending (LAD) (37.8% vs. 26.4%) was more plausible to occur 
in men compared to women (p≤0.05). 
Conclusion: Access and use of health care programs are needed to control CAD risk factors. The findings of 
the current study showed the significance of gender in the extent of coronary artery blockages. 
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INTRODUCTION
Coronary artery disease (CAD) is a costly condition 
and is considered as the leading cause of death in 
both women and men worldwide (1, 2). Directly, 
CAD is responsible for half of the cardiovascular 
deaths (3). It is estimated that, between 4% and 
10% of the patients with CAD are aged less than 
45 years old (4, 5). Furthermore, the patients with 
CAD are suffering from comorbidity diseases that 
potentially affect the treatment and risk of 
mortality (6). 
Coronary angiography is the gold standard for 
assessing the CADs. The extent and severity of 
coronary artery stenosis, the number of culprit 
vessels, the presence or the absence of 
atherosclerosis, and some other factors are useful 
indexes to determine the CAD patient's prognosis. 
This evidence is based on the coronary 
angiography findings (7, 8). Likewise, the 
angiographic evaluation of disease is very 
important for deciding on the treatment strategy. 
However, previous studies clearly demonstrated 
the limitations of coronary angiography (9, 10). 
For example, angiographic evaluation is based on 
visualizing the vessel lumen; therefore, it is not 
ideal for the assessment of complex lesions like 
bifurcation lesions (8).  
Risk factors of CAD are classified into modifiable 
and non-modifiable factors. Accordingly, Non-
modifiable are some factors such as age, family 
history, and gender. Also, Modifiable risk factors 
are hypertension, dyslipidemia, obesity, smoking, 
diabetes, and psychosocial stress. Moreover, there 
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are differences in the prevalence of risk factors 
between men and women (11); though, the 
reasons for this sex-based difference have not 
been clear, yet. 
To this end, the current study was conducted on 
the patients who were referred for coronary 
angiography at Imam Ali cardiovascular center at 
Kermanshah University of Medical Science 
(KUMS) between March and April 2018, to assess 
the gender differences in risk factor profile and 
coronary angiography, and also the other likely 
associated factors.   
Methods 
Study population and design 
This cross-sectional study was conducted in Imam 
Ali cardiovascular center at KUMS. Imam Ali 
hospital, as the main cardiovascular center in 
western Iran with 280 active beds, is a public 
hospital, and covers about two millions population 
who are mostly Kurdish.  
With the aim of evaluating only 50% of the 
patients, six-month data of the patients admitted 
for coronary angiography were assessed. From 
March-1 to August-30 2018, we evaluated all the 
patients (convenience sampling) referred for 
coronary angiography. Thus, all the patients who 
met the inclusion criteria were selected to be 
included in the study. Inclusion criteria were as 
follows: age ≥ 18 years old. The patients were 
excluded from the study if they were non-
residential (living in other countries like Iraq), 
and/or had incomplete personal or medical 
information.  
Instrument and data collection 
A research assistant, extracted the data from the 
patients’ medical records (both paperwork 
records and electronic medical records) using a 
checklist. Checklist was developed and then 
verified by expert opinions compromising a 
cardiologist, a physician, a statistician, and a PhD 
in health promotion. For the goals of this study, 
demographic characteristics (e.g. gender), clinical 
histories (e.g. previous myocardial infarction), 
cardiovascular risk factors (e.g. smoking), 
presentation assessment (e.g. heart rate), 
biochemical and lab parameters (e.g. total 
cholesterol), angiographic findings (e.g. 
topography of significant stenosis), and 
recommendations were obtained. 
Statistical methods  
Baseline data including demographic 
characteristics and cardiovascular risk factors 
were compared between men and women. Normal 
distributed variables (e.g., age) were described 
using mean ± standard deviation (µ±SD), and 
qualitative/categorical variables (e.g., smoking) 
were expressed as frequencies and percentages. 
Differences between men and women were 
assessed using independent t-tests for continuous 
and normally distributed variables, and chi-square 
(or Fisher exact tests) for qualitative/categorical 
variables. The effect size scores were calculated 
for better comparing the differences between men 
and women, using Cohen's d for continuous 
variables and chi-square (or Fisher exact tests) 
value for qualitative/categorical variables. 
Cohen's d was calculated by the difference in the 
means of the two groups divided by the weighted 
pooled standard deviations of these groups. A test 
was considered as significant if the probability 
value (p-value) was less than 0.05. The Statistical 
Package for Social Science (SPSS) software, 
version 23 (IBM Corp., Armonk, NY USA) was used 
for analyzing. 
Ethical approval 
The research ethics committee at KUMS 
(IR.KUMS.REC.1398.702) has approved the study 
protocol and has monitored the research process. 
Moreover, the individual personal information has 
been kept confidentially with access limited to 
researcher.  
RESULTS 
During the study period, a total of 741 patients, 
compromising 415 (56%) men and 326 (44%) 
women met the inclusion criteria of this study. 
The demographic and clinical characteristics of 
patients (N=741), stratified by sex are reported in 
table 1. The mean age of the women was 
60.77±9.16 years old, and for men, it was 
59.30±11.17 years old (p =0.284). A significant 
difference was observed in presenting the risk 
factors of CAD based on sex. Men had, on average, 
higher body mass index (BMI) than the women 
patients as follows: 42.09±16.68 for men and 
29.12±4.72 for the women (p=0.001). The 
prevalence rates of diabetes mellitus, 
hypertension, and hypercholesterolemia were 
significantly higher in women compared to men, 
whereas more men were current smoker (p 
≤0.05). 
The mean heart rate of the patients was 
79.29±10.77 for men vs. 80.18±11.07 for women 
(p=0.541). The mean systolic blood pressure 
(SBP) of men was 145.56±22.86 mm hg, whereas 
for women, it was 163.27±20.97 mm hg 
(p=0.008). The mean diastolic blood pressure 
(DBP) of the patients was 85.0±10.71 mm hg for 
men vs. 86.29±12.26 mm hg for women (p=0.391). 
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Also, the median ejection fraction (EF) for women 
was 48.89 ± 8.76 and for men 46.85 ± 9.86 
(p=0.145).  
The mean glucose plasma levels for men was 
117.39±39.32 vs. 123.32±55.19 for women 
(p=0.012). Comparing the lipid profiles, we 
observed that, mean total cholesterol 
(200.41±59.20 vs. 159.37±48.78) and mean serum 
triglycerides (160.74±65.97 vs. 134.30±54.52) 
were significantly higher in women compared to 
men (p≤0.05). Likewise, both atherogenic (low-
density lipoprotein (LDL)) and protective (high-
density lipoprotein (HDL)) cholesterols were 
significantly higher in women than men (p≤0.05).   
Table 1: The demographic and clinical characteristics of patients (N=741), stratified by sex 
Variable Men (n=415) Women (n=326) Effect size† (p-value) 
Age (y)¶ 59.30±11.17 60.77±9.16 0.14 (0.284)* 
Body mass index (kg/m2)¶ 42.09±16.68 29.12±4.72 1.07(0.001)* 
Current smoker 213 (28.7) 0 (0) 234.22 (<0.001)** 
Diabetes mellitus  74 (17.8) 114 (34.9) 28.32 (<0.001)*** 
Hypercholesterolemia 71 (17.1) 86 (26.4) 9.39 (0.002)** 
Hypertension 188 (45.3) 234 (71.7) 52.20(<0.001)** 
Prior congestive heart failure 0 (0) 0 (0) NAN** 
Prior myocardial infraction 52 (12.5) 31 (9.5) 1.67 (0.195)** 
Prior angina 203 (48.9) 169 (51.8) 0.62 (0.429)** 
Prior stroke 6 (1.4) 0 (0) 1.93 (0.261)** 
Prior percutaneous coronary intervention 12 (2.9) 3 (0.9) 3.57 (0.058)** 
Prior coronary artery bypass grafting 12 (2.9) 3 (0.9) 3.57 (0.058)** 
Aspirin user 296 (71.3) 255 (78.2) 4.55 (0.032)** 
Clopidogrel user 99 (23.8) 74(22.7) 0.13 (0.711)** 
Angiotensin receptor blockers user 105 (25.3) 120 (36.8) 11.43 (<0.001)** 
Beta-Blocker user 227 (54.7) 216 (66.2) 10.14 (0.001)** 
Angiotensin converting enzyme inhibitors user 48 (11.5) 74 (22.7) 16.45 (<0.001)** 
Statin user 249 (60.0) 209 (64.1) 1.30 (0.253)** 
Cholesterol¶ 159.37±48.78 200.41±59.20 1.65 (0.001)* 
Low-density lipoprotein ¶ 86.66±26.89 114.65±37.38 1.39 (0.001)* 
High-density lipoprotein ¶ 41.13±10.26 49.83±15.29 0.62 (0.021)* 
Triglycerides¶ 134.30±54.52 160.74±65.97 0.45 (0.043)* 
Glucose plasma¶ 117.39±39.32 123.32±55.19 0.53 (0.012)* 
† The effect size scores were reported using Cohen's d for continuous variables and chi-square (or Fisher exact tests) value for 
qualitative/categorical variables.  
¶ Continuous variables expressed as mean ± SD, otherwise n (%).  
* t-test; ** chi-square; *** Fisher exact test 
 
Table 2: Procedural and angiographic characteristics according to sex 
Variable Men (n=415) Women (n=326) Effect size† p-value 
Final diagnosis    
Normal coronary 151 (36.4) 188 (57.7) 33.32 (<0.001)** 
One-vessel disease 57 (13.7) 41 (12.6) 0.21 (0.644)** 
Two-vessel disease 77 (18.5) 31 (9.5) 11.99 (<0.001)** 
Three-vessel disease 121 (29.1) 63 (19.3) 9.45 (0.002)** 
Left main disease 18 (4.3) 10 (3.0) 0.80 (0.368)** 
Culprit vessel    
Left Anterior Descending 157 (37.8) 86 (26.4) 10.86 (<0.001)** 
Left Main Stem 18 (4.3) 10 (3.0) 0.80 (0.368)** 
Right Coronary Artery 120 (28.9) 47 (14.4) 21.98 (<0.001)** 
Circumflex 108 (26.0) 50 (15.3) 12.42 (<0.001)** 
Posterior Descending Artery 15 (3.8) 9 (2.7) 0.42 (0.514)** 
First Diagonal branch 61 (14.7) 43 (13.2) 0.34 (0.557)** 
Second Diagonal branch 31 (7.4) 15 (4.6) 2.58 (0.108)** 
Ramus 13 (3.1) 9 (2.7) 0.08 (0.767)** 
Saphenous Vein Graft 0 (0) 0 (0) NAN** 
First Obtuse Marginal branch 27 (6.5) 21 (6.4) 0.001(0.971)** 
Second Obtuse Marginal branch 9 (2.2) 4 (1.2) 0.93 (0.332)** 
Recommendations after angiography   
Percutaneous Coronary Intervention 83 (20.0) 54 (16.5) 1.42 (0.231)** 
Coronary Artery Bypass Grafting 130 (31.3) 69 (21.2) 9.59 (0.001)** 
Medical Follow Up 183 (44.1) 192 (58.9) 15.99 (<0.001)** 
† The effect size scores were reported using Cohen's d for continuous variables and chi-square (or Fisher exact tests) value for 
qualitative/categorical variables. 
** chi-square  
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Similar treatment patterns existed for medication 
use, however, women were more likely to take 
beta-blocker (p=0.001), angiotensin converting 
enzyme (ACE) inhibitors (p<0.001), Aspirin 
(p=0.032), and angiotensin receptor blockers 
(ARBs) (p<0.001) compared to men. 
Angiographic findings (Table 2) demonstrated 
that, men were more likely to have two-vessel 
disease (p<0.001) and three-vessel disease 
(p=0.002), whereas women were more likely to 
have normal coronary (p<0.001). No significant 
sex differences were observed in left main disease. 
The distribution of stenosis in different coronary 
arteries was compared in both genders. Stenosis 
in left anterior descending (LAD) was observed in 
51 (37.8%) men compared to 28 (26.4%) women 
(p<0.001). right coronary artery (RCA) stenosis 
was more frequent in men (120(28.9%) vs. 
47(14.4%)) (p<0.001). In circumflex (LCx), 
stenosis was observed in 108(26.0%) men 
(p<0.001). Also after angiography evaluation, men 
were significantly recommended to seek 
treatment with coronary artery bypass grafting 
(CABG) (p= 0.001), whereas medical follow up 
was significantly recommended to women 
(p<0.001).  
DISCUSSION 
The results of this study illustrated that, women 
who were referred for coronary angiography, had 
significantly higher prevalence of diabetes, 
hypertension, and hypercholesterolemia. This 
result was in line with the findings reviewed from 
the West (12-14). However, men were more likely 
to be current smokers and had higher BMI 
compared to their women counterparts. 
Consistent with the results of this study, Deepti et 
al. reported that, women were more likely to be 
hypertensive and were less likely to be current 
smokers (15). Bajaj's study performed in India, 
reported a higher prevalence of diabetes and 
hypertension among women in 2013, whereas 
men were more likely to be smoker and obese.11 
Hemal K et al. have reported that, women who 
undergoing coronary angiography were more 
likely to be hypertensive and dyslipidemic. In 
current study, women were more likely to be 
dyslipidemic, which this result support the 
findings of study done by Hemal K et al (16). 
On the other hand, many others report found 
converse results. For instance, Gupta et al. and 
Anand et al., showed a higher prevalence of 
diabetes and hypertension among men compared 
to women (17, 18). Conversely, Butala NM et al. 
and Jarrah et al., reported a higher BMI in women 
compered to men (13, 19). Also in contrast, in 
previous studies done by Yasar et al., Bajaj et al., 
and Enas et al., dyslipidaemia was more common 
among men compared to women patients (11, 14, 
20).  
Smoking was one of the significant risk factors in 
men who undergone coronary angiography, 
whereas it was totally absent in women. In fact, 
the potential reason why women refuse from 
smoking may be due to the socio-cultural factors 
in Iran where smoking is less common among 
women. Our results are in agreement with the 
findings of previous studies conducted on 
different populations in other countries (11, 17, 
18, 21). 
Comparing the lipid profiles, we found that, total 
cholesterol, serum triglycerides, LDL, and HDL 
levels were significantly higher in women 
compared to their male counterparts. These 
results support the findings of Deepti's study 
reporting that, total cholesterol, LDL, and HDL 
levels were more in women than men (15). 
However, in contrast, in a study conducted by 
Bajaj et al, the mean LDL, HDL, and serum 
triglycerides levels were higher among men than 
women (11). 
Our results demonstrated that, the mean SBP was 
significantly higher in women compared to men. 
This might be explained by the possible negative 
effect of menopause on the blood pressure. In this 
study, women had the age between 40 and 71 
years old (menopause age). Increase in plasma 
rennin activity and salt sensitivity with 
sympathetic activity due to physiological and 
hormonal changes in menopause (the declining 
estrogen levels), can lead to an increase in the 
blood pressure in peri-menopausal and post-
menopausal women (22). 
Given that the mean SBP (140≤), total cholesterol 
(160≤), glucose plasma (100≤), and BMI (25≤) 
was higher than normal range in both sex. 
Tailoring healthcare interventions to control the 
hypertension, dyslipidemia, diabetes and obesity 
epidemic, including early detection and 
management, especially those targeted the women 
(because women had worse risk profiles), should 
be a top priority in the coming years. Moreover, 
educational campaigns and programs to promote 
lifestyle can be cost-benefit in improving the 
population level. Moreover, policy interventions 
might be beneficial in modifying unhealthy habits 
and improving lifestyle, for example Colchero et al. 
found that implementing the excise tax on sugar 
sweetened beverages in Mexico leads to a 
considerable reduction in purchasing the taxed 
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beverages and an increase in purchasing the 
bottled water (23).  
In our study, similar treatment patterns 
recommended for both sex, although, women 
were more likely than men to be taking 
antiplatelet (Aspirin) and antihypertensive 
therapies (beta-blocker, ARBs, and ACE 
inhibitors). Hemal K et al. have reported that 
women were more likely than men to take β-
blockers, however, by contrast, they were less 
likely to be taking ACE inhibitors or ARBs (16). 
These differences may be due to the higher 
incidence of CAD risk factors i.e. hypertension 
among women. 
We found that men were more likely to have two-
vessel disease and three-vessel disease. The 
results were concurrent with the findings of the 
study conducted by George et al., which have 
reported two-vessel disease was more common to 
men (24). Likewise, Bajaj et al. showed multiple 
vessel disease was more common in men (11). A 
study by Jong et al. showed women were more 
likely than men to have normal coronary arteries 
(25). Some previous studies, although, showed no 
such gender differences (19, 26-28). In fact, the 
findings of current study showed the significance 
of gender in the extent of coronary artery 
blockages. Likewise, the results of current study 
indicated that disease in the RCA, LCx, and LAD 
was more plausible to occur in men. George and 
colleagues have reported that stenosis in RCA and 
LCx were more frequent in men, whereas no sex 
differences were seen in LAD disease (26). 
Furthermore, our findings show after angiography 
assessment men were more recommended to seek 
treatment with CABG and percutaneous coronary 
intervention, whereas medical follow up were 
recommended to women. This may be due to 
nearly half of the men had multi-disease vessel, 
whereas majority of women had normal coronary. 
Limitations 
The most important limitation of the current study 
was poor documentation in the past medical 
recorded information. To move bias, we tested the 
data though electronic medical records (hospital 
information system). Furthermore, our data were 
derived from a single center; hence, our 
participants may not be the representative of the 
whole patients undergoing CAG. 
CONCLUSIONS 
The results showed that women had the more 
adverse clinical risk profiles. In general, women 
were more likely to be hypertensive, diabetic, and 
dyslipidemic, whereas, men were more likely to be 
current smokers and obese. Likewise, women 
were more likely than men to be taking 
antiplatelet and antihypertensive therapies. 
Access and use of health care programs to control 
the hypertension, dyslipidemia, diabetes and 
obesity epidemic, in particular for women, are 
needed. Men were more likely than women to 
have two-vessel disease and three-vessel disease 
and, also, disease in the RCA, LCx, and LAD was 
more plausible to occur in men. 
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